DexTech Medical AB (XSAT:DEX) Cash per Share: kr0.55 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:DEX DexTech Medical AB XSAT:DEX
23 GF Score
Price kr10.25
! 2 Warning Signs
View Full Analysis

What is DexTech Medical AB Cash per Share?

DexTech Medical AB XSAT:DEX +2.50% 23 Cash per Share is kr0.55 as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). DexTech Medical AB's Cash per Share for the quarter that ended in Mar. 2026 was kr0.55.

DexTech Medical AB  (XSAT:DEX) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

DexTech Medical AB Cash per Share Related Terms

DexTech Medical AB Cash per Share Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Cash per Share Chart

DexTech Medical AB Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 1.92 1.37 1.03 0.80

DexTech Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.80 0.76 0.66 0.55
XSAT:DEX
23GF Score
DexTech Medical AB XSAT:DEX
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

DexTech Medical AB's Cash per Share for the fiscal year that ended in Jun. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=14.709/18.49
=0.80

DexTech Medical AB's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=10.118/18.49
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of kr0.55 mean?
DexTech Medical AB (XSAT:DEX) has a Cash per Share of kr0.55 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for DexTech Medical AB and its competitors.
Is DexTech Medical AB's Cash per Share too high?
DexTech Medical AB's current Cash per Share is kr0.55. Overall, DexTech Medical AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Cash per Share compare to VRTX and REGN?
DexTech Medical AB's Cash per Share of kr0.55 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Biotechnology company?
A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for DexTech Medical AB and its competitors. DexTech Medical AB's current Cash per Share is kr0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Cash per Share of kr0.55. The current Cash per Share is kr0.55. DexTech Medical AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Cash per Share is kr0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
23GF Score

Get the complete analysis for XSAT:DEX

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.25
Price